Bovine Adenovirus Types: Veterinary Reference

Overview and Taxonomy of Bovine Adenovirus Types

The genus Mastadenovirus, a constituent of the family Adenoviridae, encompasses a diverse array of pathogens that infect mammalian hosts, including economically significant livestock species. Within this genus, Bovine Adenoviruses (BAdVs) represent a group of non-enveloped, double-stranded DNA viruses that are ubiquitous in cattle populations worldwide. Their fundamental role in the bovine respiratory disease complex (BRDC), their capacity for persistent infection, and their recent emergence as promising platforms for vectored vaccines and gene therapy have propelled them into the forefront of veterinary virological research. A comprehensive understanding of their taxonomy, genomic architecture, and phylogenetic relationships is therefore not merely an academic exercise but a prerequisite for robust diagnostics, effective vaccine development, and informed epidemiological surveillance.

Historical Serological Classification and the BAdV Subgroup Paradigm

The initial classification of BAdVs was predicated upon serological cross-reactivity and distinct biological properties, most notably their differential ability to agglutinate rat erythrocytes and their variable dependency on an arginine-rich environment for efficient replication in vitro. This foundational work, largely established in the latter half of the 20th century, delineated two principal subgroups. Subgroup 1, which comprises BAdV types 1, 2, and 3, is characterized by a shared complement-fixing antigen and a distinct hemagglutination profile. The production of monospecific reference sera against these early isolates, such as the BAdV-3 Weybridge strain in gnotobiotic calves, was instrumental in establishing this initial framework and remains a cornerstone of historical reference [5]. These early reagents allowed for the unambiguous serotyping of field isolates and underpinned the initial understanding of BAdV epidemiology.

In contrast, Subgroup 2 encompasses a larger and more antigenically heterogeneous collection of serotypes, BAdV types 4 through 8 and beyond. Members of this subgroup exhibit a distinct hemagglutination pattern and possess a different major neutralizing antigenic determinant. The reference strain for Subgroup 1, “Adeno III WBR - 1,” has served as the prototypical lineage for subsequent genomic and functional studies [1]. This historical dichotomy, while biologically useful, is now being revised and refined through the lens of modern molecular phylogenetics, which has revealed a more nuanced and complex evolutionary history that does not always align perfectly with serological boundaries.

Molecular Taxonomy: Genomic Architecture and Phylogenetic Divergence

The advent of whole-genome sequencing has revolutionized the taxonomic framework for BAdVs. The BAdV genome, typically 30–36 kilobases in length, is a linear double-stranded DNA molecule with inverted terminal repeats (ITRs) that facilitate replication. The genome is organized into early (E1–E4) and late (L1–L5) transcription units, with the late regions encoding structural proteins, including the major capsid protein hexon, the penton base, and the fiber protein. The hexon gene, in particular, harbors hypervariable regions that determine serotype specificity and are the primary target for molecular diagnostic assays, such as the multiplex quantitative real-time PCR (qPCR) developed for the concurrent detection of BRDC pathogens [3]. The highly conserved nature of the hexon gene within a given serotype, contrasted with its variability between serotypes, makes it an ideal locus for phylogenetic inference and molecular epidemiology.

Phylogenetic analyses based on the hexon and fiber gene sequences have generally corroborated the two-subgroup classification but have also illuminated significant intra-subgroup diversity. For example, extensive sequencing of BAdV-3 isolates, such as the BO/YB24/17/CH strain, has revealed naturally occurring genomic deletions and mutations, particularly within the fiber gene, which encodes the primary receptor-binding protein responsible for viral attachment to host cells [2]. The fiber protein's knob domain dictates cellular tropism by interacting with specific host receptors, such as the coxsackievirus-adenovirus receptor (CAR) or sialic acid moieties. The discovery of a natural partial deletion of the fiber gene in a field isolate underscores the remarkable genomic plasticity of BAdVs and suggests that these viruses can evolve novel tropisms and pathogenic potential through recombination or deletion events [2]. Furthermore, the use of non-human adenoviruses, including BAdVs, as vector platforms for gene therapy and recombinant vaccines has spurred intensive genomic characterization. The detailed mapping of the E1 region, which is routinely deleted to create replication-deficient vectors, is a direct outcome of this molecular taxonomic effort [6]. Understanding the precise genetic makeup of each BAdV type is critical for designing vectors with optimal safety, immunogenicity, and targeted cell transduction.

Clinical and Epidemiological Significance of BAdV Types

BAdVs are implicated in a spectrum of clinical manifestations, most notably as primary or secondary agents in the bovine respiratory disease complex (BRDC), a multifactorial syndrome that constitutes a leading cause of morbidity, mortality, and economic loss in the feedlot and dairy industries. The prevalence of BAdV-3, as detected by molecular surveillance, underscores its significance as a component of this disease complex, with recent multiplex qPCR studies reporting detection rates of 22.32% in clinically affected cattle [3]. While BAdV-3 is frequently isolated from the respiratory tract, its pathogenic role can be potentiated by co-infections with other viral and bacterial pathogens, such as Mycoplasma bovis, Pasteurella multocida, and Bovine Respiratory Syncytial Virus (BRSV) [7]. The virus primarily targets epithelial cells of the upper and lower respiratory tract, leading to necrotizing bronchiolitis and interstitial pneumonia, although infection can often be subclinical.

Beyond respiratory disease, BAdV infections are also associated with enteric disease, conjunctivitis, and occasional systemic involvement. Experimental infection of BALB/c mice with the fiber-deleted BAdV-3 strain BO/YB24/17/CH demonstrated a broadened tissue tropism, with viral antigen detected not only in the lungs but also in the heart, liver, spleen, and kidneys, indicating that genomic alterations can profoundly impact pathogenicity and systemic spread [2]. This expanded tropism is of significant concern as it may correlate with more severe clinical outcomes or facilitate novel routes of transmission. The development of sophisticated diagnostic tools, such as the multiplex qPCR assay targeting the hexon gene of BAdV-3 [3] and the use of BAdV-1 as a specificity control in BVDV RT-PCR panels [4], highlights the practical importance of accurate taxonomic identification for disease surveillance and control programs. Agencies such as the World Organisation for Animal Health (WOAH) recognize the significant impact of BRDC pathogens, including BAdV, and advocate for robust diagnostic and surveillance frameworks to mitigate their economic toll.

Taxonomic Implications for Vaccine Development and Vectorology

The precise taxonomic classification of BAdV types has direct and consequential implications for the development of effective vaccines. The antigenic distinctiveness of Subgroup 1 and Subgroup 2 viruses means that immunity conferred by one type may not confer cross-protection against another. Therefore, multivalent vaccines must carefully consider the circulating serotypes within a given geographic region. Furthermore, the detailed genomic characterization of BAdV isolates, such as the reference strain “Adeno III WBR - 1” [1] and the novel BO/YB24/17/CH [2], provides the molecular blueprint for the rational design of live-attenuated or vectored vaccines. The identification of naturally attenuated strains, such as those with deletions in the fiber gene, could be exploited to generate safer vaccine candidates with reduced pathogenic potential.

Concurrently, the use of BAdV genomes as xenogenic vectors for gene therapy and vaccination has emerged as a vibrant field of research. Non-human adenoviruses, including several BAdV types, offer significant advantages over human adenoviral vectors, primarily due to the absence of pre-existing neutralizing immunity in the human population [6]. This allows for more efficient gene delivery and a more robust and durable transgene expression. The fiber protein, which dictates receptor usage, is a key determinant of vector tropism. By swapping fiber genes between different BAdV types or between BAdVs and other mastadenoviruses, researchers can engineer vectors with precisely tailored cell-targeting capabilities [6]. The development of these advanced vector systems relies entirely on a high-resolution understanding of BAdV taxonomy, enabling the selection of optimal backbone genomes that are both stably attenuated and highly immunogenic. This translational application elevates the study of BAdV taxonomy from a purely descriptive discipline to a critical component of modern biomedical engineering.

Molecular Pathogenesis: Genomic Variation and Viral Replication Mechanisms

The molecular pathogenesis of bovine adenovirus (BAdV) infections is a complex interplay between the virus’s genomic architecture, its capacity for genetic variation, and its intricate replication strategy within the host cell. Unlike many RNA viruses that exhibit high mutation rates due to error-prone polymerases, BAdV, as a double-stranded DNA virus, possesses a relatively stable genome. However, as recent discoveries have highlighted, significant genomic variation, including large deletions and recombination events, can profoundly alter viral tropism, pathogenicity, and the host immune response. Understanding these molecular underpinnings is critical for developing effective diagnostics, vaccines, and therapeutic interventions for bovine respiratory disease complex (BRDC), a syndrome of immense economic importance to the global cattle industry, as recognized by the World Organisation for Animal Health (WOAH).

Genomic Architecture and the Hexon as a Molecular Determinant

The BAdV genome, approximately 30-36 kb in length, is organized into early (E1A, E1B, E2, E3, E4) and late (L1-L5) transcription units, a structure conserved among mastadenoviruses. The hexon protein, the major capsid component encoded by the L3 region, is a primary target for both diagnostic detection and immune neutralization. Its hypervariable regions (HVRs) are under significant selective pressure from the host humoral immune system, leading to antigenic diversity. This molecular variability is the basis for serotype classification and is exploited in molecular diagnostics. For instance, the highly sensitive and specific multiplex qPCR assay developed by Li et al. (2025) targets a conserved region of the hexon gene for BAdV-3 detection, achieving a detection limit of 74.4 copies/μL [3]. The hexon gene’s stability in conserved regions makes it an ideal target for pan-serotype screening, while its variable regions are essential for serotype-specific identification, a critical factor for epidemiological surveillance and vaccine strain selection. The hexon’s role extends beyond structure; it is a key pathogen-associated molecular pattern (PAMP) that triggers innate immune responses, and its interaction with cellular integrins facilitates viral internalization.

The Fiber Gene: A Hotspot for Variation and Altered Tropism

The most striking example of genomic variation affecting BAdV pathogenesis is found in the fiber gene. The fiber protein, a homotrimer projecting from each vertex of the icosahedral capsid, is the primary determinant of viral tropism, mediating attachment to the host cell receptor. The knob domain of the fiber binds to the coxsackievirus-adenovirus receptor (CAR) or other cellular receptors, dictating cell-type specificity. A landmark study by Li et al. (2023) characterized a novel BAdV-3 isolate, BO/YB24/17/CH, which harbors a natural, partial deletion in the fiber gene [2]. This is not a minor point mutation but a substantial genomic deletion that fundamentally alters the virus-host interaction.

The molecular consequences of this deletion are profound. In a BALB/c mouse model, the fiber-deleted strain exhibited a dramatically expanded tissue tropism compared to previously reported wild-type BAdV-3 strains [2]. While wild-type BAdV-3 is typically restricted to the respiratory tract (lungs and trachea), the BO/YB24/17/CH isolate was detected in multiple organs, including the heart, liver, spleen, kidney, and even the blood [2]. This suggests that the deletion in the fiber knob may ablate high-affinity binding to CAR, forcing the virus to utilize alternative, lower-affinity receptors or entry pathways, such as integrins or sialic acid residues, which are more ubiquitously expressed across different tissues. This shift from a CAR-dependent to a CAR-independent entry mechanism can lead to a systemic infection, as observed. Furthermore, the deletion may alter the virus’s ability to evade innate immune detection or modulate the host’s antiviral state, contributing to the observed histopathological lesions, including pulmonary punctate hemorrhage, lobular atrophy, and splenomegaly [2]. This natural mutant serves as a stark warning: genomic deletions, often considered attenuating, can paradoxically enhance virulence and broaden tropism under certain selective pressures, complicating our understanding of BAdV pathogenesis.

Viral Replication Kinetics and Cellular Tropism In Vitro

The replication cycle of BAdV is a tightly regulated, multi-step process that is highly dependent on the host cell’s transcriptional and translational machinery. The efficiency of this cycle varies significantly across different cell types, a phenomenon directly linked to the expression of viral receptors and intracellular factors. Mukhammadiev et al. (2025) conducted a comprehensive optimization of BAdV-3 cultivation conditions across several continuous cell lines, providing critical insights into its replication dynamics [1]. Their work demonstrated that the MDBK (Madin-Darby bovine kidney) cell line exhibited the highest sensitivity to BAdV-3 infection, with a maximum viral titer of (6.55±0.21) lg TCID50/cm² achieved using a roller cultivation method [1]. This high titer is attributable to the robust expression of CAR and other entry co-factors on MDBK cells, coupled with their permissive intracellular environment for adenoviral DNA replication and late gene expression.

The study revealed that peak viral accumulation in the culture fluid occurred 24 hours post-infection at a multiplicity of infection (MOI) of 0.0001 [1]. This rapid replication kinetics is characteristic of a lytic infection, where the virus hijacks the cell’s machinery to produce progeny virions, culminating in cell lysis and release. The stationary cultivation method allowed for efficient adaptation of the virus to BHK-21/13, Taurus-1, KST, and MDBK cell lines, but the roller method provided superior yields due to enhanced oxygenation and nutrient distribution, which are critical for maintaining cell viability during the viral lytic cycle [1]. This in vitro data is essential for vaccine production and diagnostic antigen preparation, as it defines the optimal conditions for high-yield virus propagation. The ability to achieve high titers in a well-characterized cell line like MDBK is a prerequisite for developing inactivated or live-attenuated vaccines, as well as for producing antigens for serological assays.

The Role of Genomic Variation in Immune Evasion and Pathogenesis

Beyond the fiber gene, other regions of the BAdV genome are subject to variation that can influence pathogenesis. The E3 region, in particular, is a hotbed for genetic diversity among adenoviruses, encoding proteins that modulate the host immune response. While specific data on BAdV E3 variation is limited in the provided sources, by analogy with human adenoviruses (HAdVs), the E3 proteins (e.g., E3-19K, RIDα/β) are known to downregulate MHC class I expression, inhibit apoptosis, and counteract tumor necrosis factor (TNF)-mediated lysis. Genomic variation in this region could alter the virus’s ability to establish persistent infections or evade cytotoxic T lymphocyte (CTL) responses, contributing to the chronicity of BRDC.

The emergence of the fiber-deletion mutant [2] underscores a critical principle in viral pathogenesis: genomic plasticity can lead to unpredictable phenotypic outcomes. The fact that this isolate was detected in 2020 suggests that such variants are circulating in the field and may be underdiagnosed by standard PCR assays targeting conserved regions of the hexon. This has direct implications for molecular surveillance. The multiplex qPCR assay developed by Li et al. (2025) targets the hexon gene, which is highly conserved, and would likely detect this mutant [3]. However, a fiber-specific PCR would fail, highlighting the need for multi-target diagnostic approaches to capture the full spectrum of circulating BAdV strains. The expanded tropism of the fiber-deleted strain also raises concerns about its potential to cause more severe or disseminated disease in cattle, possibly contributing to the high prevalence (22.32%) of BAdV-3 observed in clinical BRDC cases [3].

Implications for Vaccine Development and Antiviral Strategies

The detailed understanding of BAdV genomic variation and replication mechanisms is foundational for rational vaccine design. The hexon and fiber proteins are the primary targets for neutralizing antibodies. A vaccine based on a wild-type fiber sequence may not provide complete protection against a fiber-deleted variant. Conversely, the fiber-deleted strain itself, despite its enhanced tropism in mice, could potentially be explored as a live-attenuated vaccine vector if its virulence is attenuated in cattle, a strategy successfully employed for other adenoviral vectors [6]. The use of nonhuman adenoviruses, including bovine, as gene delivery vectors is a growing field, as they circumvent pre-existing immunity to human adenoviruses (HAdV) [6]. The replication kinetics data from Mukhammadiev et al. [1] provide the necessary framework for producing such vectors at scale.

Furthermore, the identification of the fiber deletion as a key pathogenic determinant opens avenues for targeted antiviral therapies. Small molecules or peptides that block the interaction between the fiber knob and its cognate receptor could be effective against wild-type strains. However, the existence of fiber-independent entry pathways, as demonstrated by the mutant, suggests that a combination of antiviral strategies targeting multiple steps of the replication cycle (e.g., viral DNA polymerase inhibitors, protease inhibitors) may be necessary for broad-spectrum efficacy. The development of such therapies is crucial, given the economic burden of BRDC and the increasing global focus on reducing antibiotic use in food animals, a priority for the World Health Organization (WHO) and the Food and Agriculture Organization (FAO).

Epidemiology and Host Range of Bovine Adenoviruses

The epidemiological landscape of bovine adenoviruses (BAdVs) is characterized by a complex interplay of viral genetic diversity, host susceptibility factors, and environmental transmission dynamics that collectively determine the global distribution and clinical impact of these pathogens. As members of the family Adenoviridae, genus Mastadenovirus, BAdVs are classified into at least 10 distinct serotypes (BAdV-1 through BAdV-10), which are further subdivided into subgroups based on genomic and antigenic characteristics. Among these, BAdV type 3 (BAdV-3) has emerged as the most extensively studied serotype due to its consistent association with bovine respiratory disease complex (BRDC) and its demonstrated ability to cross species barriers under experimental conditions [1–3]. The present section provides a thorough examination of the epidemiological patterns and host range parameters that define BAdV infections, drawing upon recent molecular diagnostic advances, experimental pathogenesis studies, and field surveillance data to construct a comprehensive picture of these viruses in both natural and experimental host systems.

Host Range and Species Tropism

The natural host range of BAdVs is primarily restricted to bovine species, with cattle (Bos taurus and Bos indicus) serving as the principal reservoir and target population. However, the host range is broader than historically appreciated, as evidenced by experimental infections in laboratory rodents and the detection of BAdV-related sequences in diverse mammalian species. The reference strain “Adeno III WBR – 1,” representing BAdV subgroup 1, demonstrates the capacity to replicate in a variety of continuous cell culture lines derived from both bovine and non-bovine sources [1]. Specifically, Mukhammadiev et al. (2025) demonstrated that this strain rapidly adapts to BHK-21/13 cells (derived from newborn Syrian hamster kidney), alongside bovine-derived lines including Taurus-1 (calf kidney), KST (endothelium of coronary vessels of embryo cow), LEK (epithelium of lung embryo of cattle), and MDBK (Madin-Darby bovine kidney) [1]. Among these, the MDBK cell line exhibited the highest sensitivity to infection, with maximum viral accumulation observed at 24 hours post-infection at a multiplicity of infection (MOI) of 0.0001 TCID50 per cell [1]. The roller cultivation method further enhanced viral titers, achieving a maximum of 6.55 ± 0.21 log TCID50/cm² [1]. These findings underscore the remarkable adaptability of BAdV-3 to heterologous cell systems, a property that has significant implications for both laboratory propagation and potential cross-species transmission.

The experimental host range of BAdV-3 was dramatically expanded by the work of Li et al. (2023), who characterized a novel isolate (BO/YB24/17/CH) possessing a natural partial deletion in the fiber gene [2]. When inoculated intranasally into 3-week-old BALB/c mice, this isolate produced mild but consistent clinical signs, including lethargy, weight loss, anorexia, and rough hair coat. Gross pathological examination revealed pulmonary punctate hemorrhage, lobular atrophy, and splenomegaly, while histopathological analysis demonstrated thickening of alveolar septa and splenic architectural disruption characterized by mildly dilated splenic nodules and blurred red-white medullary demarcation [2]. Immunohistochemical staining confirmed that these lesions were directly attributable to viral infection. Critically, and in marked contrast to previously reported BAdV-3 strains that were detected exclusively in the respiratory tract, this fiber-deletion mutant disseminated to multiple organs, including the heart, liver, spleen, kidney, and blood, as confirmed by virus isolation, titration, and real-time PCR [2]. This expanded tissue tropism in a heterologous host suggests that the fiber protein plays a pivotal role in determining both host range and systemic dissemination capacity. The fiber gene deletion likely alters receptor-binding specificity, potentially allowing the virus to utilize alternative cellular receptors present on a wider array of cell types and across species barriers. This finding has profound implications for understanding BAdV pathogenesis and zoonotic potential, as it demonstrates that naturally occurring genetic variants can possess enhanced cross-species infectivity.

Geographical Distribution and Prevalence Patterns

BAdVs are distributed globally, with seroprevalence and infection rates varying considerably by geographic region, management system, and diagnostic methodology. The development of highly sensitive molecular tools has revolutionized our ability to detect BAdV infections in field populations. Li et al. (2025) established a multiplex quantitative real-time PCR (qPCR) assay targeting conserved regions of six major BRDC pathogens, including the hexon gene of BAdV-3 [3]. When applied to 224 naturally diseased cattle in China, this assay revealed a BAdV-3 detection rate of 22.32% (50/224), making it the second most frequently detected pathogen after Mycoplasma bovis (27.23%, 61/224) [3]. This prevalence is notably higher than that observed for bovine respiratory syncytial virus (BRSV; 7.59%), bovine parainfluenza virus type 3 (BPIV3; 11.61%), bovine viral diarrhea virus (BVDV; 8.04%), and infectious bovine rhinotracheitis virus (IBRV; 8.04%) in the same cohort [3]. Furthermore, the overall mixed infection rate was 25% (56/224), indicating that BAdV-3 frequently participates in polymicrobial infections characteristic of BRDC. These data position BAdV-3 as a quantitatively significant contributor to bovine respiratory disease in Chinese cattle populations and suggest that its role may be underestimated in regions where diagnostic panels do not include BAdV-specific targets.

The economic impact of BAdV infections, while difficult to quantify precisely, is inextricably linked to their role in BRDC, a syndrome that inflicts substantial losses on the global cattle industry. The World Organisation for Animal Health (WOAH) recognizes BRDC as a major constraint to bovine productivity worldwide, and the Food and Agriculture Organization of the United Nations (FAO) has highlighted the need for improved diagnostic and control strategies for respiratory pathogens in cattle. Given that BAdV-3 contributes to this complex with prevalence rates exceeding 20% in some studies [3], the economic burden attributable to adenoviral infections is far from negligible. However, it is essential to note that BAdVs can also be detected in apparently healthy animals, and subclinical infections are common. This complicates the establishment of causal relationships between viral detection and clinical disease, particularly in the absence of concurrent bacterial or viral co-infections. The refined multiplex qPCR approach developed by Li et al. (2025), with detection limits as low as 74.4 copies/μL for BAdV-3 and coefficients of variation below 4%, provides a robust tool for future epidemiological surveillance and for disentangling the contribution of BAdV-3 from that of co-infecting pathogens [3].

Transmission Dynamics and Risk Factors

The transmission of BAdVs occurs predominantly via the fecal-oral and respiratory routes, reflecting the dual tropism of these viruses for both the respiratory epithelium and the gastrointestinal tract. Infected cattle shed virus in nasal secretions, saliva, and feces, with shedding patterns influenced by the age and immune status of the host, the viral serotype, and the presence of concurrent infections. Young calves are particularly susceptible to BAdV infection, and the virus can circulate persistently within herds, especially under intensive management conditions where stocking density, stress, and commingling of animals from different sources facilitate viral spread. The role of persistently infected or latently infected carriers in maintaining BAdV within populations is not fully elucidated, but the ability of adenoviruses to establish latent infections in lymphoid tissues is well-documented for other mastadenoviruses and likely applies to BAdVs as well. Environmental contamination with feces and respiratory secretions contributes to indirect transmission, and BAdVs are relatively resistant to inactivation, allowing them to persist in the environment for extended periods.

Several risk factors modulate the epidemiology of BAdV infections. Age is a critical determinant, with the highest infection rates observed in calves and young stock, likely due to waning maternal antibody levels and the naivety of the developing immune system. Management practices that increase stress, such as weaning, transportation, castration, and dietary changes, predispose animals to BAdV infection by compromising mucosal immunity and altering respiratory tract clearance mechanisms. The role of co-infections cannot be overstated; BAdV-3 is frequently detected in association with M. bovis, BRSV, BPIV3, BVDV, and IBRV [3], and the synergistic interactions among these pathogens exacerbate clinical disease severity. Nutritional status, trace mineral deficiencies (particularly selenium and vitamin E), and poor ventilation in confinement housing further amplify susceptibility.

Geographic variation in BAdV prevalence is influenced by herd size, biosecurity practices, and the presence of other respiratory pathogens. In the Danish study by Tegtmeier et al. (1999), which examined pneumonic lungs from 72 calves, bovine adenovirus was investigated in 45 cases using histopathological and microbiological methods [7]. While this study focused on a northern European context and utilized diagnostic approaches that predate the widespread application of molecular PCR techniques, the findings nonetheless established that BAdV is a component of the bovine respiratory disease landscape in Europe. The lower detection rates in older studies likely reflect the comparatively lower sensitivity of virus isolation and antigen detection methods relative to modern qPCR, suggesting that historical prevalence figures may substantially underestimate the true burden of BAdV infection. The situation is further complicated by the existence of multiple serotypes with varying degrees of pathogenicity and host range, as well as the emergence of genetic variants, such as the fiber-deletion mutant identified by Li et al. (2023), that may possess altered epidemiological characteristics [2].

The One Health implications of BAdV host range warrant careful consideration, particularly given the experimental demonstration of BAdV-3 replication in BALB/c mice [2]. While there is no current evidence that BAdVs cause natural disease in humans, the ability of these viruses to infect a rodent species raises questions about the potential for emergence in new hosts under selective pressure. The Centers for Disease Control and Prevention (CDC) maintains surveillance for novel viral pathogens with zoonotic potential, and the documented ability of non-human adenoviruses to serve as gene delivery vectors [6] further underscores the need to understand their natural host range and tissue tropism. The close phylogenetic relationship between bovine and human adenoviruses, coupled with the demonstrated ability of BAdVs to utilize coxsackievirus-adenovirus receptor (CAR) or alternative receptors for cell entry [6], provides a molecular basis for potential cross-species transmission events. Continued genomic surveillance of BAdV populations, particularly in regions with intensive livestock production and close human-animal contact, is essential for early detection of host range expansion events.

Clinical Signs and Pathological Lesions in Cattle

Bovine adenovirus (BAdV) infections in cattle present a complex and often subclinical to moderately severe clinical picture, with expression heavily modulated by viral genotype, host immune status, age, and the presence of concurrent pathogens. The most comprehensive clinical descriptions arise from investigations into the bovine respiratory disease complex (BRDC), where BAdV, particularly BAdV type 3, has been established as a significant component of the polymicrobial etiology. In large-scale surveillance of naturally occurring bovine respiratory disease, BAdV-3 has been detected in 22.32% (50/224) of clinical cases, underscoring its substantial epidemiological footprint within the respiratory disease spectrum [3]. Importantly, over one-quarter (25%) of diseased cattle in that cohort exhibited mixed infections involving two or more of the six major BRDC pathogens, a finding that critically informs the interpretation of clinical signs attributable specifically to BAdV [3].

Respiratory Disease Complex and Mixed Infections

The clinical expression of BAdV-3 in cattle is most frequently dominated by respiratory signs, yet the virus seldom acts in isolation. Within the BRDC framework, BAdV-3 circulates alongside bovine respiratory syncytial virus (BRSV), bovine parainfluenza virus type 3 (BPIV3), bovine viral diarrhea virus (BVDV), Mycoplasma bovis, and infectious bovine rhinotracheitis virus (IBRV) [3]. This polymicrobial context renders the attribution of specific clinical signs to BAdV alone challenging but is biologically critical. The virus is believed to act as an initiator of respiratory disease, damaging the respiratory epithelium and thereby predisposing the lower airways to secondary bacterial invasion, particularly by Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni.

Clinical signs in naturally infected calves and young stock typically include serous to mucopurulent nasal discharge, conjunctivitis, pyrexia (often reaching 40–41°C), tachypnea, dyspnea, and a soft, moist cough. Affected animals exhibit lethargy, reduced feed intake, and a resultant depression in growth performance. The severity of disease is markedly age-dependent; in calves under six months of age, the clinical course may progress to severe bronchopneumonia with significant morbidity and mortality, whereas in older cattle, infection may be entirely subclinical or manifest as a mild, transient febrile episode. Abortions and enteric disease have also been sporadically associated with BAdV infections, though the respiratory tract remains the principal target organ system.

Systemic Signs and Sequelae

Experimental inoculation studies, including those using murine models, provide valuable mechanistic insights into the potential for systemic dissemination of BAdV-3, although direct extrapolation to cattle requires caution. In BALB/c mice intranasally inoculated with a novel BAdV-3 strain (BO/YB24/17/CH) harboring a natural deletion in the fiber gene, infected animals developed mild clinical signs including lethargy, progressive weight loss, loss of appetite, and piloerection [2]. Gross pathological examination revealed pulmonary punctate hemorrhage, lobular atrophy, and splenomegaly [2]. Of particular significance, and a departure from previously reported BAdV-3 biology, this fiber-gene deletion isolate was detected in multiple organs beyond the traditional respiratory tract, including the heart, liver, spleen, kidney, and blood [2]. This suggests that certain BAdV-3 genotypes may possess an expanded tropism, raising the possibility that in cattle, systemic dissemination could occur under specific conditions, potentially leading to hepatic, cardiac, or renal involvement that is not currently recognized in natural bovine infections.

Gross Pathological Lesions

The macroscopic lesions of BAdV infection in cattle are predominantly confined to the respiratory tract and are best characterized in the context of comprehensive pathological surveys. In a seminal study of 72 pneumonic calf lungs submitted to the Danish Veterinary Laboratory, bovine adenovirus was identified in a subset of examined cases, and the associated pathological patterns were delineated [7]. Based on histopathological classification, pneumonic lungs were categorized as fibrinous and/or necrotizing bronchopneumonia, suppurative bronchopneumonia, or embolic pneumonia [7]. BAdV was found in conjunction with other pathogens, but the lesions attributed to viral infection commonly include cranioventral consolidation of the lung lobes, particularly the apical and cardiac lobes. Affected lung tissue is typically firm, dark red to gray, and fails to collapse upon opening the thoracic cavity. Cut surfaces exude serosanguinous fluid, and the interlobular septa are often distended with edema fluid, giving the lung a characteristic lobular patterning.

In cases where BAdV acts as a primary pathogen without extensive secondary bacterial invasion, the lesions may be more subtle: multifocal areas of atelectasis, scattered petechial hemorrhages on the pleural and cut surfaces, and a mild to moderate hyperplasia of bronchial-associated lymphoid tissue (BALT). The tracheobronchial and mediastinal lymph nodes are frequently enlarged, edematous, and congested, reflecting the regional immune response to viral replication. While splenomegaly has been reported in experimental murine infections [2], this finding has not been consistently documented in bovine field cases and may represent a species-specific or strain-specific phenomenon.

Histopathological Findings

The microscopic pathology of BAdV infection in cattle reflects the virus’s primary tropism for epithelial cells of the respiratory tract. Histological examination reveals a spectrum of changes ranging from mild to severe, depending on the stage of infection and the presence of concurrent pathogens. In the early phase, the bronchiolar and alveolar epithelium exhibits evidence of direct viral cytopathology: epithelial cells become swollen, vacuolated, and eventually undergo necrosis and sloughing into the airway lumen. Intranuclear inclusion bodies, the hallmark of adenovirus infection, may be observed in infected epithelial cells. These inclusions are typically basophilic to amphophilic, enlarge the nucleus, and are surrounded by a clear halo, consistent with the replication strategy of adenoviruses within the nucleus.

The alveolar septa become thickened due to congestion, edema, and infiltration of mononuclear inflammatory cells, predominantly macrophages and lymphocytes [2]. In the Danish calf lung study, the predominant histopathological diagnoses were fibrinous and/or necrotizing bronchopneumonia and suppurative bronchopneumonia [7]. In fibrinous bronchopneumonia, the alveolar spaces are filled with a proteinaceous exudate rich in fibrin, neutrophils, and cellular debris, often reflecting the synergistic action of viral damage and secondary bacterial infection. In cases of suppurative bronchopneumonia, the exudate is dominated by neutrophils, indicating a robust acute inflammatory response. The combined presence of viral inclusions and bacterial colonies within the same histological section is not uncommon, illustrating the potentiation of bacterial invasion by prior or concurrent viral infection.

Pathogenesis and Immunopathology

The pathogenesis of BAdV-induced lesions in cattle is a multistep process beginning with viral entry via the respiratory route. The virus utilizes the coxsackievirus-adenovirus receptor (CAR) and integrins for attachment and internalization into respiratory epithelial cells [6]. Following replication, cellular lysis releases progeny virions that infect adjacent cells, leading to the characteristic epithelial necrosis and desquamation. This breach of the epithelial barrier exposes the underlying basement membrane and connective tissue, facilitating bacterial adherence and invasion. The resultant inflammatory cascade, mediated by cytokines, chemokines, and recruitment of neutrophils and macrophages, contributes to the exudative and proliferative changes seen histologically. The immune response, while essential for viral clearance, also contributes to tissue damage through the release of reactive oxygen species and proteolytic enzymes from activated inflammatory cells.

The ability of BAdV to establish persistent or latent infections in lymphoid tissues, particularly in tonsils and Peyer’s patches, complicates the clinical picture. Recrudescence of virus shedding under conditions of stress or immunosuppression may lead to intermittent respiratory disease episodes within a herd, perpetuating the cycle of infection and making eradication challenging. This carrier state is a significant consideration for herd-level management and biosecurity protocols, as apparently healthy animals can serve as sources of infection for naive cohorts.

The recognition of BAdV as a component of the BRDC has profound implications for diagnostic and control strategies. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) emphasize the importance of comprehensive surveillance and accurate pathogen identification in managing respiratory disease in cattle populations. The high detection rates of BAdV-3 in BRDC cases [3] underscore the necessity for its inclusion in routine diagnostic panels, particularly given its potential to predispose animals to more severe bacterial pneumonias. The economic impact of BRDC, driven by mortality, reduced weight gain, treatment costs, and carcass condemnation, is substantial and warrants a coordinated, evidence-based approach to prevention, including vaccination and management practices aimed at reducing viral circulation and stress-related immunosuppression.

Diagnostic Techniques for Bovine Adenovirus Detection

The accurate and timely detection of bovine adenovirus (BAdV) is a cornerstone of effective veterinary virology, underpinning both clinical management of respiratory and enteric disease outbreaks and large-scale epidemiological surveillance. Given the economic impact of bovine respiratory disease complex (BRDC), in which BAdV type 3 is a recognized contributor, and the potential for diverse clinical presentations across serotypes, a comprehensive diagnostic armamentarium is required. Contemporary diagnostics for BAdV have evolved from classical virological methods, such as virus isolation and serological profiling, to highly sensitive molecular techniques capable of simultaneous multi-pathogen detection. This section provides an exhaustive analysis of these methodologies, detailing their mechanistic principles, operational parameters, and diagnostic utility, as grounded in the most current research.

Molecular Detection: Real-Time PCR and Multiplex Assays

Polymerase chain reaction (PCR), particularly in its real-time quantitative format (qPCR), has become the gold standard for direct pathogen detection in veterinary medicine due to its exceptional sensitivity, specificity, and speed. For BAdV, the hexon gene is the preferred molecular target, as it encodes the major capsid protein and contains conserved regions across different serotypes while also harboring serotype-specific variable loops. This dual character allows for both broad BAdV detection and, with careful primer design, differentiation of specific types.

Multiplex qPCR for BRDC Pathogens. The complexity of BRDC, which can involve viral (BAdV-3, BRSV, BPIV-3, BVDV, IBRV) and bacterial (e.g., Mycoplasma bovis) co-infections, necessitates diagnostic approaches that can identify multiple agents from a single sample. A landmark advancement in this area is the establishment of a multiplex fluorescent qPCR assay specifically designed to detect six major BRDC-associated pathogens simultaneously [3]. In this assay, the BAdV-3 component targets a conserved region of the hexon gene, ensuring robust detection of this serotype [3]. The analytical performance of this multiplex system was rigorously validated, demonstrating a lower limit of detection for BAdV-3 at 74.4 copies/μL of plasmid DNA standard [3]. The assay parameters further underscore its reliability, with a coefficient of variation below 4% and amplification efficiency ranging from 93.84% to 111.60% [3]. This level of precision is critical for research applications, such as quantifying viral load in pathogenesis studies, as well as for routine clinical diagnostics where accurate differentiation between single and mixed infections informs treatment and biosecurity protocols. Indeed, in a field study of 224 natural disease cases, the assay revealed a BAdV-3 detection rate of 22.32% and a mixed infection rate of 25% among all tested cattle, validating its utility in uncovering the true complexity of BRDC etiology [3].

Applications in Pathogenesis and Epidemiology. The sensitivity of qPCR is also instrumental in expanding our understanding of BAdV pathogenesis. A study investigating a novel BAdV-3 isolate (BO/YB24/17/CH) with a natural partial deletion in the fiber gene utilized real-time PCR alongside virus isolation to map viral distribution in experimentally infected BALB/c mice [2]. This molecular approach was pivotal in demonstrating, for the first time, that BAdV-3 could be detected not only in the respiratory tract (lungs and trachea) but also in multiple other organs including the heart, liver, spleen, kidney, and blood [2]. Without the high sensitivity of qPCR, such systemic dissemination might have been missed by less sensitive methods, altering our understanding of the pathogenic potential of certain BAdV-3 strains. Furthermore, the capacity to detect viral nucleic acid in blood highlights the potential for hematogenous spread, a finding with significant implications for disease control and transmission risk assessment.

Specificity and Quality Control. The specificity of these molecular assays is paramount, especially given the potential for cross-reactivity with other bovine viruses. In the development and validation of a commercial RT-PCR test system for Bovine Viral Diarrhea Virus (BVDV), researchers critically assessed cross-reactivity by testing the assay against BAdV type 1 (strain Bovina-10). The results confirmed 100% specificity, with no amplification detected from the BAdV-1 genome [4]. This rigorous evaluation, which also included testing against Infectious Bovine Rhinotracheitis virus and Parainfluenza-3 virus, sets a standard for quality assurance that should be applied to all commercial and in-house BAdV diagnostic assays to prevent false-positive results and ensure clinical accuracy [4].

Virus Isolation and Cell Culture Optimization

Despite the dominance of molecular techniques, virus isolation remains an indispensable tool for the definitive identification of infectious virus, the generation of viral stocks for research and vaccine development, and the characterization of novel strains. The success of isolation is intrinsically linked to the selection of an appropriate cell line and the optimization of cultivation conditions.

Comparative Evaluation of Cell Lines. The choice of cell line is a critical determinant of isolation efficiency. A comprehensive optimization study compared the susceptibility of five continuous cell lines to infection with the reference BAdV-3 strain “Adeno III WBR - 1” [1]. The cell lines evaluated included BHK-21/13 (baby hamster kidney), Taurus-1 (calf kidney), KST (bovine embryo coronary vessel endothelium), LEK (bovine embryo lung epithelium), and MDBK (Madin-Darby bovine kidney). The study demonstrated that while the virus adapted to BHK-21/13, Taurus-1, KST, and MDBK under stationary cultivation, the highest sensitivity to infection was observed with the MDBK cell line, achieving the most efficient infection at a multiplicity of infection (MOI) of 0.0001 TCID50/cell [1]. This finding reinforces the widespread use of MDBK cells as the preferred substrate for primary BAdV-3 isolation and propagation in many diagnostic laboratories.

Maximizing Viral Yield. The objectives of diagnostics and research often extend beyond simple detection to include the production of high-titer virus for downstream applications. The same study investigated the effect of different cultivation methods on viral yield using MDBK cells. A comparative assessment revealed that the roller bottle cultivation method, which involves the continuous gentle rotation of culture vessels, significantly enhanced viral accumulation compared to static (stationary) culture [1]. Using this method, a maximum virus titer of (6.55 ± 0.21) log10 TCID50/cm² was achieved in the culture fluid, with peak accumulation occurring 24 hours post-infection [1]. This finding has direct operational implications: for diagnostic laboratories that require high-titer positive controls for PCR or serological assays, or for research groups preparing viral antigens, the roller technique offers a clear advantage over stationary flasks. The rapid 24-hour harvest time also facilitates faster turnaround for research protocols.

Serological Detection and Reference Standards

While direct detection of the virus or its genome is preferred for diagnosing active infection, serological assays, which detect antibodies produced by the host in response to infection, are essential tools for epidemiological surveys, vaccination monitoring, and determining the seroprevalence of BAdV within a herd.

Monospecific Reference Sera. The foundation of reliable serology is the availability of high-quality, specific reference reagents. The production of monospecific reference sera against bovine adenovirus type 3 (alongside other bovine viruses) has been achieved through the use of gnotobiotic (germ-free) calves [5]. These animals, lacking pre-existing antibodies to common pathogens, provide an immunologically naive background. When inoculated with a pure BAdV-3 antigen, they produce antisera of exceptionally high titer in a shorter time frame compared to conventional animals [5]. Crucially, subsequent testing confirmed that these sera were free of heterologous antibody activity against other bovine viruses, ensuring their monospecificity [5]. The production and lyophilization of such standard reference antisera, as described in early studies, remain vital for calibrating ELISA tests, performing serum neutralization assays, and ensuring inter-laboratory comparability in BAdV diagnostics [5].

Mechanisms of Serological Testing. The most common serological methods applied to BAdV include the virus neutralization test (VNT) and enzyme-linked immunosorbent assays (ELISAs). VNT is a functional assay that measures the titer of antibodies capable of preventing virus infection in cell culture, thereby providing a measure of protective immunity. ELISA, particularly the indirect format, uses purified BAdV antigens to capture specific antibodies in serum samples, offering a faster, higher-throughput alternative to VNT. The availability of monoclonal antibodies against specific BAdV structural proteins, such as the hexon or fiber, could further refine these assays, enabling the differentiation of antibody responses to natural infection versus those induced by vaccines based on modified viral vectors, a topic of growing interest as nonhuman adenoviruses, including bovine types, are developed for gene delivery and recombinant vaccines [6]. The development of such differentiation tests is critical for monitoring vaccine efficacy and distinguishing vaccinated animals from those that are naturally infected, a key component of disease control programs advocated by organizations like the World Organisation for Animal Health (WOAH).

In Vitro Cultivation and Adaptation to Continuous Cell Lines

The successful isolation, propagation, and characterization of bovine adenoviruses (BAdVs) are fundamentally contingent upon the availability of permissive cell culture systems that support robust viral replication. Unlike many fastidious pathogens that require complex, organotypic, or primary cultures, BAdVs, particularly those of subgroup 1, such as BAdV-3, have demonstrated a notable capacity for adaptation to established, continuous cell lines. This adaptability has been instrumental in advancing our understanding of BAdV biology, facilitating the development of diagnostic reagents, and enabling the production of vaccine antigens and vector platforms. The systematic optimization of cultivation parameters, including cell line selection, inoculation multiplicity, harvest timing, and physical culture method, is critical for maximizing viral yield and maintaining genetic stability. The work of Mukhammadiev et al. [1] provides a seminal framework for understanding these parameters, systematically evaluating the susceptibility of several continuous cell lines to BAdV-3 and establishing benchmark protocols for high-titer production.

Historical Context and the Imperative for Continuous Cell Lines

Historically, the isolation of bovine adenoviruses relied heavily on primary or early-passage cell cultures derived from bovine tissues, such as fetal kidney or testis cells. While effective, primary cultures suffer from inherent limitations: batch-to-batch variability, finite lifespan, risk of adventitious agent contamination from the donor animal, and the logistical burden of continuous tissue procurement. The shift toward continuous cell lines, immortalized, stable, and well-characterized substrates, represented a paradigm shift in veterinary virology. The development of lines such as Madin-Darby Bovine Kidney (MDBK), BHK-21 (baby hamster kidney), and various bovine embryonic cell lines provided standardized, reproducible platforms for viral cultivation. As noted by Christofinis et al. [5], the production of monospecific reference antisera against BAdV-3 (Weybridge strain) was successfully accomplished using gnotobiotic calves, but the downstream antigen production for such sera and for diagnostic tests inevitably required scalable cell culture systems. The adaptation of BAdVs to continuous lines is not merely a matter of convenience; it is a prerequisite for modern applications, including the development of recombinant adenoviral vectors for gene therapy and vaccination, as explored extensively with non-human adenoviruses [6].

Systematic Evaluation of Permissive Cell Lines: A Comparative Analysis

The landmark study by Mukhammadiev et al. [1] offers the most comprehensive comparative assessment of BAdV-3 cultivation on continuous cell lines to date. The investigators evaluated five distinct lines: BHK-21/13 (newborn Syrian hamster kidney), Taurus-1 (calf kidney), KST (coronary vessel endothelium of the bovine embryo), LEK (lung epithelium of the bovine embryo), and MDBK (Madin-Darby bovine kidney). Each of these lines presents a unique cellular environment, differing in receptor expression, metabolic pathways, and intrinsic antiviral responses.

The study revealed that the BAdV-3 strain (Adeno III WBR-1) adapted rapidly to BHK-21/13, Taurus-1, KST, and MDBK under stationary cultivation conditions. This rapid adaptation suggests a degree of plasticity in the viral attachment and entry mechanisms, allowing the virus to exploit receptors present on cell surfaces across species (hamster and bovine) and tissue origins. However, a critical distinction emerged in the sensitivity of these lines. The MDBK cell line demonstrated the highest sensitivity, with a minimal infectious dose of 0.0001 MOI/cell being sufficient to establish a productive infection [1]. This finding underscores that while many lines may support viral replication, the efficiency of the initial infection event, likely governed by the density and affinity of viral receptors such as the coxsackievirus-adenovirus receptor (CAR) or integrins, is markedly higher in MDBK cells. The MDBK line, an established standard in bovine virology, appears to provide the most favorable receptor milieu for BAdV-3 attachment and internalization.

In contrast, the LEK line (bovine embryonic lung epithelium) showed comparatively lower sensitivity. This differential susceptibility may reflect tissue-specific expression patterns of viral receptors. Adenoviruses are known to utilize CAR for initial attachment; the expression of CAR on kidney-derived lines like MDBK is well-documented, whereas lung epithelial cells may express a different complement of integrins or CAR isoforms. The ability of BAdV-3 to infect the KST line (endothelial origin) is particularly noteworthy from a pathogenesis perspective. Bovine adenoviruses are associated with respiratory and enteric disease, but their ability to replicate in endothelial cells in vitro using the KST line [1] provides a cellular correlate for potential hematogenous spread and vascular involvement observed in severe cases. Indeed, recent work by Li et al. [2] demonstrated that a novel BAdV-3 isolate could be detected in the blood and multiple organs (heart, liver, spleen, kidney) of experimentally infected mice, suggesting a viremic phase that would require replication within or transit through endothelial cells.

Optimization of Infection Parameters: Multiplicity of Infection and Harvest Kinetics

The efficiency of viral propagation is exquisitely sensitive to the multiplicity of infection (MOI) and the timing of harvest. For BAdV-3, Mukhammadiev et al. [1] established that the maximum accumulation of virus in the culture fluid occurred at 24 hours post-infection. This rapid replication cycle is characteristic of many mastadenoviruses and is a crucial consideration for industrial-scale production. Harvesting too early yields suboptimal titers, while harvesting too late exposes the virus to degradative enzymes released from lysed cells and the toxic effects of accumulated metabolic waste. The 24-hour peak provides a precise window for maximizing yield while minimizing degradation.

The MOI is equally critical. At a high MOI, the infection is synchronized, and all cells are infected simultaneously, leading to a rapid, single-cycle burst of progeny virus. However, this can also result in the production of defective interfering particles and rapid cell death before maximum viral protein synthesis is achieved. Conversely, a low MOI allows for multiple cycles of replication, potentially amplifying the virus over a longer period. The finding that MDBK cells could be productively infected at an extremely low MOI of 0.0001 TCID₅₀/cell [1] indicates an exceptional efficiency of viral spread within the monolayer. This low MOI is advantageous for seed stock preparation, as it minimizes the accumulation of mutations and defective particles that can arise from high-multiplicity passage.

Comparative Analysis of Cultivation Methods: Stationary versus Roller

The physical method of cell cultivation exerts a profound influence on viral yield. Mukhammadiev et al. [1] conducted a direct comparison between the traditional stationary (static) method and the roller (dynamic) method using the optimal MDBK cell line. The results were unequivocal: the roller cultivation method produced a significantly higher viral titer, reaching (6.55 ± 0.21) log₁₀ TCID₅₀/cm². This represents a substantial increase over yields obtained from stationary flasks.

The mechanistic basis for this superiority is multifaceted. First, the continuous rotation of roller bottles ensures uniform exposure of the cell monolayer to the nutrient medium and, critically, to the viral inoculum. In static cultures, viral adsorption is limited by diffusion, leading to gradients of infection efficiency across the monolayer. Rotation eliminates this gradient, promoting synchronous infection. Second, the dynamic environment enhances oxygen transfer to the cells, supporting higher metabolic activity and cell density over the culture period. Third, the gentle, continuous movement of the medium likely facilitates the release of progeny virions from the cell surface, preventing re-adsorption and allowing for accumulation in the supernatant. The roller method effectively increases the "working volume" of the culture by ensuring that all cells are active participants in the infection process, thereby increasing the effective surface area and cell number per unit volume of media.

This finding has direct implications for vaccine manufacturing and diagnostic antigen production. The use of roller bottles is a scalable technology that can be adapted to industrial fermenters and bioreactors. The titer achieved, over 6 logs, is sufficient for most downstream applications, including inactivation for vaccine formulation or concentration for diagnostic test development.

Implications for Reference Strain Maintenance and Vector Development

The adaptation of BAdV to continuous cell lines is not a static endpoint but a dynamic process that can influence viral characteristics. Serial passage in a heterologous cell line, such as BHK-21 (hamster origin), can select for variants that are better adapted to that specific cellular environment, potentially altering tissue tropism or virulence in vivo. For this reason, the reference strain "Adeno III WBR-1" used in the optimization studies by Mukhammadiev et al. is typically maintained on a homologous bovine line like MDBK to preserve its authentic phenotype. The development of the multiplex qPCR assay for BAV3 detection by Li et al. [3] relied on the Hexon gene as the target, and the propagation of the virus in MDBK cells would have been essential for generating the positive control standards and validating the assay.

Furthermore, the robust replication of BAdV-3 in MDBK cells makes it an attractive candidate for the development of replication-competent or replication-deficient vector systems. As Mittal et al. [6] have reviewed, non-human adenoviruses, including bovine, ovine, and porcine serotypes, are being extensively investigated as gene delivery vehicles. Their advantages include the absence of pre-existing immunity in human populations and the ability to circumvent neutralizing antibodies against human adenoviruses. The high titers achievable in MDBK cells, as demonstrated by Mukhammadiev et al. [1], provide the necessary feedstock for the production of these novel recombinant vectors.

Parallels in the Cultivation of Other Bovine Viruses

The principles governing BAdV cultivation are echoed in the propagation of other bovine pathogens. For instance, the successful isolation of bovine viral diarrhea virus (BVDV) is routinely performed on bovine cell lines such as PT-80, as described by Preobrazhenskaya et al. [4] during the validation of a BVDV RT-PCR test system. Similarly, canine distemper virus (CDV) requires Vero cells engineered to express the canine SLAM receptor [8], highlighting a common theme of receptor availability dictating cell line permissivity. For BAdVs, the natural expression of CAR on MDBK cells [1] appears to be sufficient, eliminating the need for receptor engineering and simplifying the production system. The adaptation of bluetongue virus (BTV), a reovirus, to insect cell lines (KC cells) for isolation [9] is a critical exception, underscoring that the choice of cell line must align with the specific replication strategy of the virus (cytoplasmic versus nuclear, RNA versus DNA). Adenoviruses, being DNA viruses with a nuclear replication phase, are well-suited to the mammalian cell systems optimized in these studies.

In conclusion, the in vitro cultivation of bovine adenoviruses, particularly type 3, has been thoroughly optimized. The MDBK cell line stands out as the most sensitive and productive substrate, with the roller cultivation method at a low MOI and a 24-hour harvest cycle representing the gold standard for high-titer virus production. These established protocols are foundational for ongoing research into BAdV pathogenesis, diagnostics, and the development of next-generation veterinary vaccines and gene therapy vectors.

Emerging Variants and Novel Insights from Natural Deletion Mutants

The landscape of bovine adenovirus (BAdV) research has been profoundly reshaped by the discovery and characterization of naturally occurring deletion mutants, particularly those affecting the fiber gene. These variants challenge long-held assumptions about viral tropism, pathogenicity, and the evolutionary plasticity of mastadenoviruses. The emergence of such mutants, especially within BAdV-3, provides a unique window into the molecular determinants of host range and tissue specificity, while simultaneously raising critical questions for vaccine development and diagnostic surveillance. This section delves into the biological mechanisms, epidemiological implications, and novel pathogenic insights derived from the study of these natural deletion mutants, with a primary focus on the paradigm-shifting isolate BO/YB24/17/CH.

The Discovery and Genomic Architecture of a Natural Fiber Gene Deletion Mutant

The isolation of the BAdV-3 strain BO/YB24/17/CH in 2020 marked a seminal event in the field of bovine virology [2]. Unlike laboratory-generated mutants or attenuated vaccine strains, this isolate arose naturally within a bovine host, harboring a spontaneous, partial deletion within the fiber gene. The fiber protein is the primary receptor-binding determinant for most adenoviruses, mediating the initial, high-affinity attachment to host cell receptors. For human adenoviruses, this interaction typically involves the coxsackievirus-adenovirus receptor (CAR), although other receptors such as CD46, desmoglein-2, and sialic acid residues are utilized by different serotypes [6]. In BAdV-3, the fiber protein is known to be critical for viral entry, and its structural integrity is considered essential for efficient infection of permissive cell lines like MDBK [1].

The deletion in BO/YB24/17/CH is not a complete ablation of the fiber gene but rather a partial truncation. This is a crucial distinction. A complete loss of fiber would likely render the virus non-infectious, as it would be unable to engage its primary receptor. The partial deletion, however, suggests a structural remodeling of the fiber knob or shaft domain, potentially altering its binding affinity or specificity. Genomic sequencing of this isolate revealed that the deletion does not disrupt the reading frame for the remainder of the fiber protein, implying that a truncated, yet potentially functional, fiber polypeptide is expressed on the virion surface. This structural alteration is the hypothesized molecular basis for the profound phenotypic changes observed in subsequent pathogenicity studies.

Altered Pathogenicity and Expanded Tissue Tropism in a Murine Model

The most striking finding from the characterization of BO/YB24/17/CH is its dramatically expanded tissue tropism and altered pathogenicity in a BALB/c mouse model [2]. Historically, BAdV-3 has been considered a respiratory pathogen, with its replication largely confined to the upper and lower respiratory tract, particularly the lungs and trachea. This restricted tropism is a hallmark of the virus and is a key factor in its role within the bovine respiratory disease complex (BRDC) [3, 7]. However, when Li et al. (2023) intranasally inoculated BALB/c mice with the fiber deletion mutant, they observed a radically different pattern of dissemination.

Using virus isolation, titration, and real-time PCR, the researchers detected the mutant virus not only in the lungs and trachea but also in a wide array of extrapulmonary organs, including the heart, liver, spleen, kidney, and, critically, the blood [2]. This systemic dissemination is unprecedented for a wild-type BAdV-3 strain and indicates that the fiber deletion has fundamentally altered the virus’s ability to escape the respiratory tract and establish infection in distant tissues. The presence of the virus in the blood (viremia) is particularly significant, as it provides a direct conduit for hematogenous spread to all organ systems.

The pathological consequences of this expanded tropism were equally profound. Infected mice exhibited mild but consistent clinical signs, including lethargy, weight loss, and a rough hair coat. Gross pathological examination revealed pulmonary punctate hemorrhage, lobular atrophy, and splenomegaly [2]. Histopathological analysis confirmed the systemic nature of the infection, demonstrating thickening of alveolar septa in the lungs and, importantly, mildly dilated splenic nodules with blurred red-white medullary demarcation in the spleen. Immunohistochemical staining directly linked these lesions to the presence of viral antigen, confirming that the tissue damage was a direct result of viral replication in these ectopic sites [2]. This represents a fundamental shift in our understanding of BAdV-3 pathogenesis. The fiber deletion has effectively converted a typically respiratory-restricted virus into a multi-organ pathogen, at least in a murine model.

Mechanistic Hypotheses: From Receptor Tropism to Immune Evasion

The mechanistic basis for this dramatic phenotypic shift is a subject of intense speculation and ongoing research. The most parsimonious explanation lies in altered receptor usage. The partial deletion of the fiber knob is hypothesized to disrupt the virus’s ability to bind to its canonical receptor on respiratory epithelial cells. This could be CAR, a sialic acid-containing glycoprotein, or another, as-yet-unidentified receptor. The loss of this high-affinity interaction may be compensated for by the acquisition of a new binding specificity. The truncated fiber might now recognize a different, more ubiquitously expressed receptor present on the surface of endothelial cells, hepatocytes, renal cells, and cardiomyocytes. This would explain the virus’s newfound ability to exit the respiratory tract, enter the bloodstream, and infect a wide range of parenchymal organs.

An alternative, though not mutually exclusive, hypothesis involves immune evasion. The fiber protein is a major target of the host humoral immune response, particularly neutralizing antibodies. A significant structural alteration in the fiber could allow the virus to escape pre-existing immunity, either from a previous infection or from maternal antibodies. This immune evasion could permit a more robust and prolonged primary infection, increasing the likelihood of systemic spread. Furthermore, the deletion might affect the interaction of the virus with innate immune sensors. The fiber protein of some adenoviruses has been shown to modulate the interferon response. A truncated fiber might be less efficient at triggering these antiviral pathways, allowing the virus to replicate to higher titers and disseminate more readily before the host can mount an effective innate immune response.

Implications for BRDC Epidemiology and Diagnostic Surveillance

The emergence of a naturally occurring BAdV-3 variant with enhanced pathogenicity and systemic spread has significant implications for the understanding and management of the bovine respiratory disease complex (BRDC). BRDC is a multifactorial syndrome involving viral and bacterial pathogens, with BAdV-3 traditionally considered a minor or secondary contributor [3, 7]. The discovery of BO/YB24/17/CH suggests that the role of BAdV-3 in BRDC may be more complex and potentially more severe than previously appreciated. If such variants are circulating in cattle populations, they could act as primary pathogens capable of causing severe, multi-systemic disease, rather than simply predisposing animals to secondary bacterial pneumonia.

This finding underscores the critical need for enhanced molecular surveillance of BAdV-3 field isolates. Current diagnostic methods for BAdV-3, such as the multiplex qPCR assays described by Li et al. (2025), typically target conserved regions of the hexon gene [3]. While these assays are excellent for detecting the presence of BAdV-3, they do not discriminate between wild-type strains and potentially more virulent deletion mutants. To effectively monitor the emergence and spread of these variants, diagnostic protocols must be expanded to include genotyping of the fiber gene. This could be achieved through fiber-specific PCR assays followed by amplicon sequencing or by incorporating fiber gene probes into advanced multiplex assays. The World Organisation for Animal Health (WOAH) and national veterinary authorities should consider recommending such enhanced surveillance, particularly in regions with intensive cattle production where BRDC is endemic.

Furthermore, the existence of these variants has profound implications for vaccine development. The fiber protein is a key component of many adenovirus-based vaccines, both for BAdV-3 itself and as a vector for other pathogens [6]. If a vaccine is based on a wild-type fiber sequence, it may offer only partial protection against a fiber deletion mutant. Conversely, a vaccine strain that itself carries a fiber deletion might be more effective at inducing broad immunity, but its safety profile would need to be rigorously evaluated, given the demonstrated pathogenicity of BO/YB24/17/CH in mice. The development of a safe and effective vaccine against these emerging variants will require a detailed understanding of the structure-function relationships of the mutant fiber protein and its interaction with the host immune system.

Broader Context: Natural Deletion Mutants as a Window into Adenovirus Evolution

The BO/YB24/17/CH isolate is not an isolated anomaly but rather a powerful example of the ongoing evolutionary dynamics of adenoviruses. Adenovirus genomes are known to be relatively stable, but they are also capable of undergoing recombination and accumulating point mutations and deletions, particularly in the non-essential regions of the genome that encode proteins involved in host interaction. The fiber gene, being a major determinant of tropism and a target of immune pressure, is a hotspot for such variation. The natural deletion in BO/YB24/17/CH may represent an adaptive response to selective pressure within the bovine host, perhaps allowing the virus to infect a new cell type or to circumvent a specific immune response.

This phenomenon is not unique to bovine adenoviruses. In human adenoviruses, natural deletions and mutations in the fiber gene have been linked to altered tropism and pathogenicity. For example, certain subgenera of human adenoviruses have evolved fiber proteins that bind to different receptors, allowing them to infect a broader range of tissues. The study of natural deletion mutants in livestock species provides a valuable comparative model for understanding these evolutionary processes. It also highlights the potential for zoonotic or reverse-zoonotic events. While BAdV-3 is not currently considered a major zoonotic threat, the emergence of a variant with expanded tropism and the ability to cause systemic disease raises a theoretical concern. The Centers for Disease Control and Prevention (CDC) and the Food and Agriculture Organization (FAO) of the United Nations should be aware of these findings as part of a One Health approach to emerging infectious diseases. The ability of a non-human adenovirus to adapt to a new host environment through a simple genetic change underscores the constant threat of viral emergence from animal reservoirs.

References

[1] Mukhammadiev R, Yarullin A, Karimullina I, Galeeva A, Mukhammadiev R, Zaynullin L, et al.. Optimization of cultivation conditions for bovine adenovirus type 3. BIO Web of Conferences. 2025. DOI: https://doi.org/10.1051/bioconf/202517302010

[2] Li Q, He S, Zou Y, Yue H, Tang C, Liu J. Pathogenicity of a novel bovine adenovirus type 3 with a natural deletion partial fiber gene in BALB/c mice. Frontiers in Veterinary Science. 2023. DOI: https://doi.org/10.3389/fvets.2023.1138159

[3] Li L, Jiang Q, Li S, Li X, Sun S, Wang X, et al.. Establishment of a multiplex qPCR assay for the detection of pathogens associated with bovine respiratory disease complex. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1594488

[4] Preobrazhenskaya A, Devrishova ZS, Lobova T, Mikhailova V, Varentsova A, Amineva E, et al.. Laboratory tests of the VetMAX BVDV Screening RT-PCR test system for detecting the genome of the bovine viral diarrhea virus by ThermoFisher. Agrarian science. 2020. DOI: https://doi.org/10.32634/0869-8155-2020-338-5-28-34

[5] Christofinis G, Edington N, Betts AO, Prydie J, Pirie G. Preparation in gnotobiotic animals of monospecific reference serums against viruses.. American Journal of Veterinary Research. 1972. DOI: https://doi.org/10.2460/ajvr.1972.33.10.1915

[6] Mittal S, Ahi YS, Vemula SV. Xenogenic Adenoviral Vectors. Adenoviral Vectors for Gene Therapy. 2016. DOI: https://doi.org/10.1016/B978-0-12-800276-6.00019-X

[7] Tegtmeier C, Uttenthal A, Friis NF, Jensen N, Jensen H. Pathological and Microbiological Studies on Pneumonic Lungs from Danish Calves. Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B. 1999. DOI: https://doi.org/10.1046/j.1439-0450.1999.00301.x

[8] Yang D, Park Y, Park Y, Hyun B. Establishment of Multiplex RT-PCR for Differentiating between the CD1901 and Lederle Strains of Canine Distemper Virus. Journal of Bacteriology and Virology. 2022. DOI: https://doi.org/10.4167/jbv.2022.52.1.011

[9] Brenner J, Oura C, Asis I, Maan S, Elad D, Maan N, et al.. Multiple Serotypes of Bluetongue Virus in Sheep and Cattle, Israel. Emerging Infectious Diseases. 2010. DOI: https://doi.org/10.3201/eid1612.100239